Table of Contents

2019-2024 Global Artemisinine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artemisinine Consumption 2014-2024
2.1.2 Artemisinine Consumption CAGR by Region
2.2 Artemisinine Segment by Type
2.2.1 Extraction from Artemisia annua
2.2.2 Semisynthetic Artemisinine
2.3 Artemisinine Consumption by Type
2.3.1 Global Artemisinine Consumption Market Share by Type (2014-2019)
2.3.2 Global Artemisinine Revenue and Market Share by Type (2014-2019)
2.3.3 Global Artemisinine Sale Price by Type (2014-2019)
2.4 Artemisinine Segment by Application
2.4.1 Injections
2.4.2 Tablets
2.4.3 Others
2.5 Artemisinine Consumption by Application
2.5.1 Global Artemisinine Consumption Market Share by Application (2014-2019)
2.5.2 Global Artemisinine Value and Market Share by Application (2014-2019)
2.5.3 Global Artemisinine Sale Price by Application (2014-2019)

3 Global Artemisinine by Players
3.1 Global Artemisinine Sales Market Share by Players
3.1.1 Global Artemisinine Sales by Players (2017-2019)
3.1.2 Global Artemisinine Sales Market Share by Players (2017-2019)
3.2 Global Artemisinine Revenue Market Share by Players
3.2.1 Global Artemisinine Revenue by Players (2017-2019)
3.2.2 Global Artemisinine Revenue Market Share by Players (2017-2019)
3.3 Global Artemisinine Sale Price by Players
3.4 Global Artemisinine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Artemisinine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Artemisinine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Artemisinine by Regions
4.1 Artemisinine by Regions
4.1.1 Global Artemisinine Consumption by Regions
4.1.2 Global Artemisinine Value by Regions
4.2 Americas Artemisinine Consumption Growth
4.3 APAC Artemisinine Consumption Growth
4.4 Europe Artemisinine Consumption Growth
4.5 Middle East & Africa Artemisinine Consumption Growth

5 Americas
5.1 Americas Artemisinine Consumption by Countries
5.1.1 Americas Artemisinine Consumption by Countries (2014-2019)
5.1.2 Americas Artemisinine Value by Countries (2014-2019)
5.2 Americas Artemisinine Consumption by Type
5.3 Americas Artemisinine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Artemisinine Consumption by Countries
6.1.1 APAC Artemisinine Consumption by Countries (2014-2019)
6.1.2 APAC Artemisinine Value by Countries (2014-2019)
6.2 APAC Artemisinine Consumption by Type
6.3 APAC Artemisinine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Artemisinine by Countries
7.1.1 Europe Artemisinine Consumption by Countries (2014-2019)
7.1.2 Europe Artemisinine Value by Countries (2014-2019)
7.2 Europe Artemisinine Consumption by Type
7.3 Europe Artemisinine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Artemisinine by Countries
8.1.1 Middle East & Africa Artemisinine Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Artemisinine Value by Countries (2014-2019)
8.2 Middle East & Africa Artemisinine Consumption by Type
8.3 Middle East & Africa Artemisinine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artemisinine Distributors
10.3 Artemisinine Customer

11 Global Artemisinine Market Forecast
11.1 Global Artemisinine Consumption Forecast (2019-2024)
11.2 Global Artemisinine Forecast by Regions
11.2.1 Global Artemisinine Forecast by Regions (2019-2024)
11.2.2 Global Artemisinine Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Artemisinine Forecast by Type
11.8 Global Artemisinine Forecast by Application

12 Key Players Analysis
12.1 Guilin Pharmaceutical
12.1.1 Company Details
12.1.2 Artemisinine Product Offered
12.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Guilin Pharmaceutical News
12.2 CAT KHANH
12.2.1 Company Details
12.2.2 Artemisinine Product Offered
12.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 CAT KHANH News
12.3 Novanat Bioresource
12.3.1 Company Details
12.3.2 Artemisinine Product Offered
12.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novanat Bioresource News
12.4 BEEPZ
12.4.1 Company Details
12.4.2 Artemisinine Product Offered
12.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 BEEPZ News
12.5 KPC Pharmaceuticals
12.5.1 Company Details
12.5.2 Artemisinine Product Offered
12.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 KPC Pharmaceuticals News
12.6 BIONEXX
12.6.1 Company Details
12.6.2 Artemisinine Product Offered
12.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 BIONEXX News
12.7 Guangxi xiancaotang
12.7.1 Company Details
12.7.2 Artemisinine Product Offered
12.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Guangxi xiancaotang News
12.8 Sanofi
12.8.1 Company Details
12.8.2 Artemisinine Product Offered
12.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Sanofi News
12.9 Natural Bio-engineering
12.9.1 Company Details
12.9.2 Artemisinine Product Offered
12.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Natural Bio-engineering News
12.10 Kerui nanhai
12.10.1 Company Details
12.10.2 Artemisinine Product Offered
12.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Kerui nanhai News

13 Research Findings and Conclusion